207 related articles for article (PubMed ID: 29568692)
1. Longitudinal evaluation of Tau-P301L transgenic mice reveals no cognitive impairments at 17 months of age.
Kent BA; Heath CJ; Kim CH; Ahrens R; Fraser PE; St George-Hyslop P; Bussey TJ; Saksida LM
Brain Behav; 2018 Jan; 8(1):e00896. PubMed ID: 29568692
[TBL] [Abstract][Full Text] [Related]
2. Performance of transgenic TgTau-P301L mice in a 5-choice serial reaction time task (5-CSRTT) as a model of Alzheimer's disease.
Bharmal AV; Kent BA; Bussey TJ; Saksida LM
Psychiatr Danub; 2015 Sep; 27 Suppl 1():S515-25. PubMed ID: 26540742
[TBL] [Abstract][Full Text] [Related]
3. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).
Ramsden M; Kotilinek L; Forster C; Paulson J; McGowan E; SantaCruz K; Guimaraes A; Yue M; Lewis J; Carlson G; Hutton M; Ashe KH
J Neurosci; 2005 Nov; 25(46):10637-47. PubMed ID: 16291936
[TBL] [Abstract][Full Text] [Related]
5. Adult-onset focal expression of mutated human tau in the hippocampus impairs spatial working memory of rats.
Mustroph ML; King MA; Klein RL; Ramirez JJ
Behav Brain Res; 2012 Jul; 233(1):141-8. PubMed ID: 22561128
[TBL] [Abstract][Full Text] [Related]
6. Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model.
Jul P; Volbracht C; de Jong IE; Helboe L; Elvang AB; Pedersen JT
J Alzheimers Dis; 2016; 49(3):783-95. PubMed ID: 26519432
[TBL] [Abstract][Full Text] [Related]
7. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.
Boekhoorn K; Terwel D; Biemans B; Borghgraef P; Wiegert O; Ramakers GJ; de Vos K; Krugers H; Tomiyama T; Mori H; Joels M; van Leuven F; Lucassen PJ
J Neurosci; 2006 Mar; 26(13):3514-23. PubMed ID: 16571759
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
[TBL] [Abstract][Full Text] [Related]
9. The behavioural phenotype of 14-month-old female TAU58/2 transgenic mice.
Kreilaus F; Masanetz R; Watt G; Przybyla M; Ittner A; Ittner L; Karl T
Behav Brain Res; 2021 Jan; 397():112943. PubMed ID: 33017638
[TBL] [Abstract][Full Text] [Related]
10. T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice.
Fukushima T; Nakamura A; Iwakami N; Nakada Y; Hattori H; Hoki S; Yamaguchi H; Nakagawa M; Terashima N; Narita H
Biochem Biophys Res Commun; 2011 Apr; 407(4):730-4. PubMed ID: 21439944
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
Köhler C; Bista P; Götz J; Schröder H
Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
[TBL] [Abstract][Full Text] [Related]
12. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
13. Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology.
Koss DJ; Robinson L; Drever BD; Plucińska K; Stoppelkamp S; Veselcic P; Riedel G; Platt B
Neurobiol Dis; 2016 Jul; 91():105-23. PubMed ID: 26949217
[TBL] [Abstract][Full Text] [Related]
14. Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei.
Dutschmann M; Menuet C; Stettner GM; Gestreau C; Borghgraef P; Devijver H; Gielis L; Hilaire G; Van Leuven F
J Neurosci; 2010 Feb; 30(5):1810-21. PubMed ID: 20130190
[TBL] [Abstract][Full Text] [Related]
15. Frontotemporal Dementia P301L Mutation Potentiates but Is Not Sufficient to Cause the Formation of Cytotoxic Fibrils of Tau.
Wang KW; Zhang G; Kuo MH
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834443
[TBL] [Abstract][Full Text] [Related]
16. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
[TBL] [Abstract][Full Text] [Related]
17. Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice.
Pennanen L; Welzl H; D'Adamo P; Nitsch RM; Götz J
Neurobiol Dis; 2004 Apr; 15(3):500-9. PubMed ID: 15056457
[TBL] [Abstract][Full Text] [Related]
18. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.
Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M
Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182
[TBL] [Abstract][Full Text] [Related]
19. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP
Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255
[TBL] [Abstract][Full Text] [Related]
20. Neuropathological changes and cognitive deficits in rats transgenic for human mutant tau recapitulate human tauopathy.
Malcolm JC; Breuillaud L; Do Carmo S; Hall H; Welikovitch LA; Macdonald JA; Goedert M; Cuello AC
Neurobiol Dis; 2019 Jul; 127():323-338. PubMed ID: 30905766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
